The Priority Review

Clinical trials Brief

Cognixion enrolls participants in NIH-funded BCI study for ALS

Cognixion Corporation announced it is now enrolling 30 adults with ALS in the CHOICE study, a 12-week trial comparing its investigational brain-computer interface with eye-tracking devices. The study is supported by the National Institute on Deafness and Other Communication Disorders and is registered on ClinicalTrials.gov as NCT07871071.

Primary source

Company press release (PR Newswire), November 4, 2026

Cognixion Now Enrolling NIH-Funded Study of Wearable Brain-Computer Interface Communication Device for People with ALS

Read the source: Cognixion Now Enrolling NIH-Funded Study of Wearable Brain-Computer Interface Communication Device for People with ALS prnewswire.com

Machine-summarized from the source above; not independently reported. How we use automation